ClinicalTrials.gov record
Completed Phase 1 Interventional

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR

ClinicalTrials.gov ID: NCT06130540

Public ClinicalTrials.gov record NCT06130540. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Multicenter Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab Infusion in Adults With Giant Cell Arteritis (GCA) or Polymyalgia Rheumatica (PMR)

Study identification

NCT ID
NCT06130540
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
65 participants

Conditions and interventions

Interventions

  • Secukinumab Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 26, 2024
Primary completion
Mar 11, 2025
Completion
Apr 1, 2025
Last update posted
Mar 31, 2026

2024 – 2025

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
8
Facility City State ZIP Site status
Rheumatology Associates of South Florida Boca Raton Florida 33486
FL Medical Clinic Orlando Health Zephyrhills Florida 33542
Willow Rheumatology Wellness Willowbrook Illinois 60527
Altoona Center for Clin Res Duncansville Pennsylvania 16635
West Tennessee Research Institute Jackson Tennessee 38305
Accurate Clinical Research Inc San Antonio Texas 78229
Overlake Internal Med Associates Bellevue Washington 98004
Rheumatology Pulmonary Clinic Beckley West Virginia 25801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06130540, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 31, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06130540 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →